Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623420 | SCV000742962 | pathogenic | Inborn genetic diseases | 2017-09-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001206530 | SCV001377841 | pathogenic | not provided | 2023-12-23 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 146 of the CTSK protein (p.Gly146Arg). This variant is present in population databases (rs74315302, gnomAD 0.01%). This missense change has been observed in individuals with pycnodysostosis (PMID: 8703060, 20044043, 27558267). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8421). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CTSK protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects CTSK function (PMID: 10074491). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000008932 | SCV002796189 | pathogenic | Pyknodysostosis | 2022-01-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000008932 | SCV004049728 | pathogenic | Pyknodysostosis | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000008932 | SCV004215254 | pathogenic | Pyknodysostosis | 2024-02-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000008932 | SCV000029142 | pathogenic | Pyknodysostosis | 1996-08-30 | no assertion criteria provided | literature only | |
Natera, |
RCV000008932 | SCV002085806 | pathogenic | Pyknodysostosis | 2020-07-21 | no assertion criteria provided | clinical testing |